NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
USV Expands Diabetes Portfolio with Cost-Effective Liralin-EP in India Deeksha Bhandari22 March 2025 1:00 PM ISTUSV Pvt. Ltd., launches the Liralin EP a combination of Linagliptin & Empagliflozin at just Rs 12.90 per tablet for strengthening it's affordable...
USV Launches Xenia Brand Range Following Empagliflozin Patent Expiry Deeksha Bhandari21 March 2025 6:00 PM ISTNew Delhi: Strengthening its leadership in diabetes care, USV Pvt. Ltd. has announced the launch of its Xenia brand range, following...
CDSCO Panel suggests revising phase III CT protocol of Zydus Healthcare's Empagliflozin plus Metoprolol Succinate FDC Dr. Divya Colin15 March 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report presented by Zydus Healthcare for the fixed dose combination of empagliflozin plus...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market Antidiabetic FDC Dr. Divya Colin7 March 2025 6:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Empagliflozin Reduces CI-AKI Risk in PCI Patients by Improving Renal Function: Study Reveals Medha Baranwal8 Feb 2025 5:15 AM ISTIran: A recent randomized trial has highlighted the potential of empagliflozin in reducing the risk of contrast-induced acute kidney injury (CI-AKI)...
Empagliflozin and dapagliflozin have comparable long-term kidney outcomes in Type 2 Diabetes: JAMA Dr. Shravani Dali24 Jan 2025 9:00 AM ISTThe results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or dapagliflozin had...
Empagliflozin Aids Weight Loss in patients with Prediabetes and Diabetes, reports study Dr. Shravani Dali18 Jan 2025 9:00 AM ISTEmpagliflozin Aids Weight Loss in Prediabetes and Diabetes suggests a new study published in the Scientific Reports.The impact of blood...
